A haze is hovering over the nation's medicine chest this morning, but our vision remains clear. And we foresee yet another busy day. We hope this briefing will help you prepare for the challenges ahead...
Roche Anemia Drugs Gets FDA OK, But Patent Is An Issue (Yahoo/AP)
GPC Biotech Cutting 44 Percent Of Workforce (Bloomberg News)
Schering-Plough and OraSure End Patent Dispute (nj.com)
Novartis And Speedel Battle Over Tekturna Royalties (PharmaTimes)
Erbitux Improves Survival Rate Of Colon Cancer Patients (Forbes/Associated Press)
Hungary's Gedeon Richter To Buy Poland's Polpharma For $1.4B (Bloomberg News)
1 Comment
ED,
"a HAZE IS HOVERING OVER THE NATIONS MEDICINE CHEST"
Have you looked out the Window lately,..its pooring.